Company / Income Tax per Share
AbCellera Biologics Inc. Income Tax per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.11
FY2025
5-year range
-$0.13 / $0.14
FY2021-FY2025
Trend
+18.3%
vs FY2024
Sector context
#189 of 201
Health Care
What the data says
Among 201 Health Care companies, AbCellera Biologics Inc. is in the top 6% for income tax per share. Income Tax per Share returned to growth in FY2025 after 4 years of decline, reaching $-0.11.
Based on SEC 10-K filings.
-0.11 in FY2025.
Improved from $-0.10 to $-0.11 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 201This company -$0.11 Sector average $1.35
▼
-107.8% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 18.3% year-over-year.
- Ranks #189 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2020.
- Lowest income tax per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.11 | +18.3% |
| FY2024 | -$0.13 | -34.0% |
| FY2023 | -$0.10 | -170.1% |
| FY2022 | $0.14 | -4.9% |
| FY2021 | $0.14 | -2.4% |
| FY2020 | $0.15 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026